192 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
101 | 16759707 | An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. | 2006 Oct | 1 |
102 | 16911928 | Genetic factors for individual administration of immunosuppressants in organ transplantation. | 2006 Aug | 1 |
103 | 17042920 | Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. | 2006 Nov | 2 |
104 | 17178259 | Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. | 2006 Dec | 2 |
105 | 15723604 | Cytochrome P450 3A polymorphisms and immunosuppressive drugs. | 2005 Jan | 1 |
106 | 15845749 | Midazolam and cyclosporin a metabolism in transgenic mice with liver-specific expression of human CYP3A4. | 2005 Jul | 3 |
107 | 16027407 | Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers. | 2005 Aug | 1 |
108 | 16095503 | Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. | 2005 Sep | 1 |
109 | 16198658 | Cyclosporine markedly raises the plasma concentrations of repaglinide. | 2005 Oct | 1 |
110 | 16205037 | [Drug-drug interaction of antifungal drugs]. | 2005 Oct | 1 |
111 | 16298597 | No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem. | 2005 Oct | 1 |
112 | 16541750 | [Incremental effect and mechanism of cyclosporine on blood concentration of statins and statin package insert information in Japan]. | 2005 | 3 |
113 | 14617681 | Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the rat. | 2004 Mar | 1 |
114 | 15116055 | CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. | 2004 May | 2 |
115 | 15197524 | Gene expression of cytochromes P450 in liver transplants over time. | 2004 Aug | 3 |
116 | 15307840 | CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus. | 2004 Sep | 5 |
117 | 15350151 | Drug interactions with St John's wort : mechanisms and clinical implications. | 2004 | 1 |
118 | 15369802 | Influence of lipophilicity on the interactions of hydroxy stilbenes with cytochrome P450 3A4. | 2004 Oct 15 | 1 |
119 | 15450954 | In vitro metabolism of cyclosporine A by human kidney CYP3A5. | 2004 Nov 1 | 4 |
120 | 15454731 | The effect of variable CYP3A5 expression on cyclosporine dosing, blood pressure and long-term graft survival in renal transplant patients. | 2004 Oct | 2 |
121 | 15592326 | Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes. | 2004 Dec | 3 |
122 | 12558459 | Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients. | 2003 | 1 |
123 | 12562644 | Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer. | 2003 Feb | 2 |
124 | 12563178 | Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. | 2003 Feb | 2 |
125 | 12673034 | Induction of CYP3As in HepG2 cells by several drugs. Association between induction of CYP3A4 and expression of glucocorticoid receptor. | 2003 Apr | 6 |
126 | 12766558 | Association of the CYP3A4*1B 5'-flanking region polymorphism with cyclosporine pharmacokinetics in healthy subjects. | 2003 Jun | 1 |
127 | 12817518 | The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients. | 2003 Jun | 4 |
128 | 12966368 | Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus. | 2003 Sep | 2 |
129 | 11849198 | St Johns wort increases expression of P-glycoprotein: implications for drug interactions. | 2002 Jan | 1 |
130 | 11888457 | St John's Wort supplements endanger the success of organ transplantation. | 2002 Mar | 1 |
131 | 11914905 | Effects of paclitaxel, cyclophosphamide, ifosfamide, tamoxifen and cyclosporine on the metabolism of methoxymorpholinodoxorubicin in human liver microsomes. | 2002 Apr | 1 |
132 | 11978159 | Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole. | 2002 May | 1 |
133 | 12036392 | Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. | 2002 | 1 |
134 | 12160480 | Pharmacokinetic interactions between herbal remedies and medicinal drugs. | 2002 Jun | 1 |
135 | 12497749 | [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction]. | 2002 | 1 |
136 | 12523495 | Perazine as a potent inhibitor of human CYP1A2 but not CYP3A4. | 2002 Jul-Aug | 1 |
137 | 12698985 | Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children. | 2002 Nov | 1 |
138 | 11181682 | Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel. | 2001 Feb 15 | 2 |
139 | 11239516 | Preliminary report on the effect of xenoperfusion with human blood on cyclosporin A metabolism and cytochrome-P-4503A4-mRNA expression in a pig liver perfusion model. | 2001 Feb | 2 |
140 | 11375290 | No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients. | 2001 Jun | 2 |
141 | 11408558 | P-glycoprotein-mediated efflux of indinavir metabolites in Caco-2 cells expressing cytochrome P450 3A4. | 2001 Jul | 1 |
142 | 11549208 | Pharmacokinetics of oral cyclosporin A when co-administered to enhance the absorption of orally administered docetaxel. | 2001 Jul | 2 |
143 | 11719731 | Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipients. | 2001 Nov | 4 |
144 | 11836874 | [Safety profile of statins]. | 2001 Nov | 1 |
145 | 11871046 | St John's wort: a hidden risk for transplant patients. | 2001 Jun | 1 |
146 | 10668858 | Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. | 2000 Jan | 1 |
147 | 10741627 | Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe. | 2000 Mar | 7 |
148 | 10752642 | Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes. | 2000 Mar | 1 |
149 | 10786743 | The effect of paracetamol (acetaminophen) on fentanyl metabolism in vitro. | 2000 May | 1 |
150 | 10898107 | Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. | 2000 Jul | 2 |